Thank you for your interest in the 9th International Congress, Psoriasis: from Gene to Clinic.
The Congress will take place from Thursday 9th December – Saturday 11th December 2021 at the Queen Elizabeth II Centre, London. It will be run as a hybrid event.
Registration for the Congress is now open. Due to COVID-19 restrictions registration places are currently for virtual registration only. We hope to have a limited number of physical places available at a later date. Please indicate when registering if you wish to be considered for a physical place.
Early Registration Deadline Extended: to Monday 13th September 2021
Considerable progress has been made over recent years in our understanding of psoriasis at both fundamental basic science and clinical levels. Identification of immunopathological mechanisms that lead to the expression of disease and elucidation of cellular processes which control proliferation and differentiation are integral to the development of new therapies and therapeutic approaches specifically designed for psoriasis. Furthermore, significant progress has been made in understanding the genetic architecture of psoriasis which in turn highlight key biological pathways, some shared with other auto-immune diseases. Emerging evidence suggests that psoriasis is associated with risk of cardiovascular disease and other comorbidities. The true relationships between these conditions and determination of mechanisms will be important in the long-term management of psoriasis.
Building on the success of our previous International Congresses held every three years since 1996, Psoriasis: from Gene to Clinic is designed to provide a forum for experts from around the world to present and discuss cutting edge issues. Delegates are anticipated to include clinicians, scientists and members of the biotechnology and pharmaceutical industries.
To reflect the areas of current scientific and clinical interests, the meeting will concentrate on specific plenary topics: genes and pathogenesis; inflammation and immunity, comorbidites and targeted therapeutics.
There will be plenty of opportunity for free communications on any aspect of psoriasis, either as oral or poster presentations. Time will be available for informal discussions. The high quality of the meeting is again reflected in our choice of venue. The Queen Elizabeth II Conference Centre is uniquely situated in the shadow of Big Ben and Westminster Abbey. The welcome reception will take place at the Conference Centre and the Congress Dinner will be held at the magnificent Natural History Museum, a unique, historic venue in the heart of London.
December is an excellent time to visit London and we hope that you will be able to join us.